tiprankstipranks
Trending News
More News >
Molecular Partners AG (CH:MOLN)
:MOLN

Molecular Partners AG (MOLN) Similar Stocks

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
CHF3.37
CHF144.54M
-2.17
-23.87%
0 Buy
1 Hold
0 Sell
Hold
Idorsia Ltd
CHF4.02
CHF999.81M
-6.82
524.66%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF22.85
$457.11M
19.08
169.14%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF12.34
CHF164.92M
-2.52
12.76%
1 Buy
0 Hold
0 Sell
Moderate Buy
RELIEF THERAPEUTICS Holding
CHF1.90
CHF416.60M
-2.04
-42.68%
Xlife Sciences Ltd.
CHF23.90
CHF137.84M
4.49
-6.20%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:MOLN
Molecular Partners AG
3.53
-1.11
-23.87%
CH:IDIA
Idorsia Ltd
4.56
3.83
524.66%
CH:NWRN
Newron Pharmaceuticals SpA
22.85
14.36
169.14%
CH:SANN
Santhera Pharmaceuticals Holding
12.90
1.46
12.76%
CH:RLF
RELIEF THERAPEUTICS Holding
2.35
-1.75
-42.68%
CH:XLS
Xlife Sciences Ltd.
24.20
-1.60
-6.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts